Kathleen Laporte

Kathleen Laporte is a declared insider at 3 companies; the most frequent names are Precipio, Inc., 89bio, Inc. and Cero Therapeutics Holdings, Inc. We count 10 filings; the first trade dates from 17 July 2023 and the latest from 15 January 2026.

Every open-market trade on record is a sale: 2 sales worth €314k. The rest of the record consists of 5 share grants and 2 option exercises.

Most recently, on 20 January 2026, the filings show a share grant worth €11k in Precipio, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.